The meetings, held by the government’s initiative to speed COVID-19 vaccine and drug development, typically focus on vaccine distribution, therapeutics, manufacturing and supply issues, according to Politico.
Politico previously reported that the Biden transition team was denied access to the meetings.
The senior administration official told Politico that the Biden team had been receiving regular briefings on the meetings, but had not attended any.
Read the full article here.
More articles on pharmacy:
Gilead testing remdesivir against new COVID-19 variants
Fresenius Kabi recalls NSAID due to presence of particulate matter
CVS Health names new chief people officer
